Antibiotic resistance arising during infections is generally thought to be due to mutations in pathogen…
karnottJuly 28, 2026
BioLife Solutions, a Bothell, Wash.-based company developing tools for cell and gene therapy, is being…
karnottJuly 27, 2026
Eight researchers (including three from the Department of Medicine) will receive a total of $975,000…
karnottJuly 27, 2026
Umoja Biopharma announced that the FDA has cleared its Investigational New Drug (IND) application for…
karnottJuly 24, 2026
Watch out, metastatic ER+/HER2- breast cancer. There’s a new targeted agent in town. On Tuesday,…
karnottJuly 24, 2026
Kate Markey, MBBS, PhD, FRACP, an assistant professor at Fred Hutch Cancer Center and UW…
karnottJuly 23, 2026
Last week, Fierce Biotech released its annual list of the top emerging biotech hubs in…
karnottJuly 23, 2026
authors Ed Muir Sr. Communications Specialist The Washington State Academy of Sciences (WSAS) has recognized…
karnottJuly 22, 2026
CDK12 mutations occur in 2-7% of metastatic prostate cancers (mPCa) and are considered to be…
karnottJuly 22, 2026
